We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
DXS International Plc | AQSE:DXSP | Aquis Stock Exchange | Ordinary Share | GB00B2Q6HZ92 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.35 | 1.20 | 1.50 | 1.35 | 1.35 | 1.35 | 0.00 | 06:57:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDXSP
DXS INTERNATIONAL PLC
Notification of Director / PDMR Dealing
The Board of DXS International plc (the "Company"), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems has received notification that on 23 August 2021 Mr Bob Sutcliffe, the Chairman, purchased 10,156 Ordinary Shares in the Company at a price of 12.8p per share.
Following the transaction specified above Mr Sutcliffe has a beneficial holding of 555,538 Ordinary Shares representing 1.15% of the issued share capital of the Company.
Details of the person discharging managerial responsibilities 1 / person closely associated --- ----------------------------------------------------------------------- a) Name Robert Sutcliffe --- ---------------------------------- ----------------------------------- 2 Reason for the notification --- ----------------------------------------------------------------------- a) Position/status Chairman --- ---------------------------------- ----------------------------------- Initial notification b) /Amendment Initial --- ---------------------------------- ----------------------------------- Details of the issuer, emission allowance market participant, 3 auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------------- a) Name DXS INTERNATIONAL PLC --- ---------------------------------- ----------------------------------- b) LEI 2138001R1KEUWTXEVJ44 --- ---------------------------------- ----------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 4 have been conducted --- ----------------------------------------------------------------------- Description of the financial instrument, type of a) instrument Ordinary Shares of 0.33p each --- Identification code ISIN GB00B2Q6HZ92 b) Nature of the transaction Purchase --- ---------------------------------- ----------------------------------- c) Price(s) and volume(s) --- --------------- --------------- Price(s) Volume(s) --- --------------- --------------- 12.8p 10,156 ------------------------------------------------------ --------------- d) Aggregated information --- - Aggregated volume - Price e) Date of the transaction 23 August 2021 --- ---------------------------------- ----------------------------------- f) Place of the transaction AQSE --- ---------------------------------- -----------------------------------
The Directors of DXS International plc accept responsibility for this announcement
Enquiries:
David Immelman (Chief Executive) 01252 719800 DXS International plc david@dxs-systems.com Wrecclesham House Wrecclesham Road Farnham Surrey GU10 4PS www.dxs-systems.co.uk Corporate Advisor David Papworth City & Merchant 0207 101 7676 Corporate Broker Hybridan LLP Claire Louise Noyce 020 3764 2341
Note to Editors:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.
(END) Dow Jones Newswires
August 24, 2021 07:30 ET (11:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year DXS Chart |
1 Month DXS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions